semaglutide compounding news november 2025 FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage Semaglutide Shortage Ends: Compounded Versions

In the future, the successful development of small molecule GLP-1 receptor agonists and therapy based on glucagon and other gut hormones may provide a broader arsenal for the treatment of both hyperglycaemia and overweight

Inflamm Bowel Dis 2024 Nov 27 [Epub]

Weight Management at CU Medicine The best GLP-1 choice depends on a patients health history, preferences and access to treatment

However, this inhibitory effect is significantly weakened in patients with T2DM, indicating that its potential application in diabetes treatment requires further investigation

Orforglipron represents the oral GLP-1 frontier, potentially eliminating the need for injections altogether